Indica Labs Collaborated with iCAIRD to Develop AI-Based Algorithm for the Detection of Lymph Node Status in Colon Cancer
Shots:
- Based on the agreement, both companies will develop an AI-based digital pathology solution to improve the efficiency of detecting metastatic cancer in lymph nodes from colorectal cancer cases
- The development process will include anonymized H&E slides from NHS Greater Glasgow & Clyde’s digital pathology archive to train, validate & test the algorithm being developed. Indica’s HALO AI & HALO AP will also be used for the development of digital pathology solutions
- The AI-based digital pathology solution will be integrated with the potential to detect the presence (+ve) or the absence (-ve) of the lymph node from which the +ve lymph node will be categorized into metastases, micro-metastases & individual tumor cells
Ref: PRNewswire | Image: Indica Labs
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
